NCT07095114View on ClinicalTrials.gov

A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 18, 2025

Primary Completion Date

August 8, 2026

Study Completion Date

August 8, 2026

Conditions
Ductal Carcinoma in SituStage I Breast CancerStage II Breast CancerStage III Breast Cancer
Interventions
OTHER

Magic Ink

A novel ink that is only visible when exposed to Ultraviolet light and can be hidden using white light will be inserted into the dermis to tattoo a radiation guidance tattoo into the skin of the participant

Trial Locations (1)

48201

RECRUITING

Karmanos Cancer Institute, Detroit

All Listed Sponsors
lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT07095114 - A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients. | Biotech Hunter | Biotech Hunter